D49- neoplasms
An open-label, randomized control trial to Determine the optimal dose of megestrol acetate in advance stage cancer patients having anorexia cachexia syndrome.
Who can joinAdults
Age18+ years
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
HBCH AND MPMMCC VaranasiVaranasiDirections ↗
Registry summary (technical)
An open-label,phase III randomized control trial to observe the weight gain and appetite improvement with use of Megestrol in advanced stage cancer patients having anorexia and cachexia syndrome - NIL
Sponsor: Tata Memorial centre Administrative Research Council
CTRI/2025/04/084037 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 1 Jun 2026 · read by us 5 Nov 2026